676 related articles for article (PubMed ID: 12590850)
21. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
22. Intratympanic gentamicin therapy for Ménière's disease.
Hirsch BE; Kamerer DB
Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
[TBL] [Abstract][Full Text] [Related]
23. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial.
Postema RJ; Kingma CM; Wit HP; Albers FW; Van Der Laan BF
Acta Otolaryngol; 2008 Aug; 128(8):876-80. PubMed ID: 18607963
[TBL] [Abstract][Full Text] [Related]
24. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
Colletti V; Carner M; Colletti L
Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
[TBL] [Abstract][Full Text] [Related]
25. Effects of a single intratympanic gentamicin injection on Meniere's disease.
Chung WH; Chung KW; Kim JH; Cho YS; Hong SH
Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572
[TBL] [Abstract][Full Text] [Related]
26. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
27. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
Perez N; Martin E; Zubieta JL; Romero MD; Garcia-Tapia R
Laryngoscope; 2002 Jun; 112(6):1104-9. PubMed ID: 12160282
[TBL] [Abstract][Full Text] [Related]
28. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
Nedzelski JM; Chiong CM; Fradet G; Schessel DA; Bryce GE; Pfleiderer AG
Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
[TBL] [Abstract][Full Text] [Related]
30. Update on intratympanic gentamicin for Meniere's disease.
Blakley BW
Laryngoscope; 2000 Feb; 110(2 Pt 1):236-40. PubMed ID: 10680922
[TBL] [Abstract][Full Text] [Related]
31. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
32. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
Corsten M; Marsan J; Schramm D; Robichaud J
J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
[TBL] [Abstract][Full Text] [Related]
33. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Ménière's disease.
Hill SL; Digges EN; Silverstein H
Ear Nose Throat J; 2006 Aug; 85(8):494, 496, 498. PubMed ID: 16999055
[TBL] [Abstract][Full Text] [Related]
35. [Intratympanic gentamycin in association with human fibrin glue in the treatment of Meniere's disease: preliminary results].
Casani AP; Dallan I; Sellari-Franceschini S; Nuti D
Acta Otorhinolaryngol Ital; 2002 Aug; 22(4):199-207. PubMed ID: 12379040
[TBL] [Abstract][Full Text] [Related]
36. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
Büki B; Platz M; Haslwanter T; Jünger H; Avan P
Audiol Neurootol; 2011; 16(1):49-54. PubMed ID: 20523039
[TBL] [Abstract][Full Text] [Related]
37. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
38. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
[TBL] [Abstract][Full Text] [Related]
39. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
Kaplan DM; Hehar SS; Bance ML; Rutka JA
Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
[TBL] [Abstract][Full Text] [Related]
40. Intratympanic gentamicin for Menière's disease: a meta-analysis.
Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
